Standard milli-current TENS (transcutaneous electrical nerve stimulation) and EGS (electro- galvanic stimulation) are modalities familiar to most physical medicine professionals. Generally, currents in the range of 20 mA to 120 mA are applied to block neurological transmission of pain signals and stimulate the release of endorphins and other neurotransmitters for the relief of chronic and acute pain.
There is very little evidence that these early modalities have much therapeutic benefit beyond the simple blocking of the perception of pain. Much evidence does, however, suggest these modalities do DECREASE ATP production, one’s ability to heal, significantly.
With Acuscope & Myopulse, our instrument is able to send a current at the millionth to trillionth ampere. The amplitude of the current is much smaller than other electrical stimulation devices. Scientists conclusively established that applying millionths to trillionths of an ampere to the cellular membrane activated and opened the electrically sensitive ion channels in the cell membrane, enhancing nutrient intake and waste product departure, promoting a healthy sodium potassium pump, thus transforming a cell from a degenerative state to a regenerative state in a matter of seconds.
PAIN AND SYMPTOM MANAGEMENT USING BOTH THE ELECTRO ACUSCOPE® AND THE ELECTRO MYOPULSE® MODALITIES
Microcurrent therapy, using the effective, medical-grade instruments, The Electro Acuscope and The Electro Myopulse results in pain-free, noninvasive treatments that enhance a healthier level of conductively in the nervous system and have successfully contributed to the recovery and/or symptom management of the following:
- Painful Eczema
- Acute pain and/or new injury
- Surgical incision
- Abdominal cramps
- Stroke rehab
- Cerebral palsy (symptom management)
- Multiple sclerosis (symptom management)
- Sinus problems
- Lymphatic inflammation
- Wound healing
- Pre-op surgery
- Disc disease
- Soft tissue
- Carpal tunnel
- Muscle trauma
- Cognitive and visual impairment due caused by COVID-19 (2021-2022 studies)
- Management of blood glucose levels in patients with diabetes (2022 study)
- TMJ syndrome
Call today to schedule your INITIAL EXAM!